Stockholders Approve 1-for-25 Reverse Split to Maintain NYSE Listing

summarizeSummary

agilon health stockholders approved a reverse stock split, with the Board subsequently setting a 1-for-25 ratio, primarily to regain compliance with NYSE minimum bid price requirements and avoid delisting.

check_boxKey Events

• Reverse Stock Split Approved

  Stockholders approved an amendment to the Certificate of Incorporation to effect a reverse stock split with a ratio between 1-for-5 and 1-for-25.

• 1-for-25 Ratio Set

  The Board of Directors subsequently approved the implementation of a 1-for-25 reverse stock split.

• NYSE Listing Compliance

  The primary purpose of the reverse split is to increase the stock price above $1.00 to comply with NYSE minimum bid price requirements and avoid delisting.

• Effective Date

  The reverse stock split is expected to become effective on March 30, 2026, with trading on a split-adjusted basis beginning March 31, 2026.

auto_awesomeAnalysis

This reverse stock split is a critical step for agilon health to address its ongoing NYSE delisting threat, as previously indicated in its recent 10-K filing. While reverse splits do not change a company's fundamental value, this action is necessary to maintain the company's listing on a major exchange, which is crucial for liquidity and investor access. The 1-for-25 ratio is substantial, aiming to significantly boost the per-share price above the $1.00 minimum. Investors should monitor the stock's performance post-split and the company's ability to sustain the higher price.